Alnylam Pharmaceuticals
ALNY
#770
Rank
$33.27 B
Marketcap
$248.68
Share price
0.47%
Change (1 day)
-46.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company